Effect of kaolin clay on migrant alate aphids (Hemiptera: Aphididae) in blueberry fields in the context of Blueberry scorch virus

The efficacy of kaolin clay (Surround® WP) in reducing the number of migrant aphids on blueberry, Vaccinium corymbosum L. (Ericaceae) and the incidence of Blueberry scorch virus (BlScV) was determined. Two applications of kaolin clay reduced the number of alatae collected on treated ‘Berkeley’ plants by as much as a factor of eight between 4 June and 16 August. However, five of 100 test plants located near infected fields and exposed only to migrant alatae between 10 May and 16 August became infected with BlScV: three controls and two treated with kaolin clay. The work demonstrates the importance of migrant alatae in the spread of BlScV; 5% transmission is consistent with previous estimates of annual virus spread by winged and non-winged aphids. Three of the plants became infected between 10 and 27 May (one control and two treated with kaolin clay), indicating the importance of aphid flights in May for virus transmission. Rainfall removed much of the kaolin clay and this may have affected its efficacy. The aphid data demonstrated that migrant alatae are able to discriminate between untreated and kaolin—treated blueberry plants, and that Ericaphis fimbriata (Richards), which utilizes blueberry as a host, discriminates better than other migrant species. Water trap data do not necessarily reflect the total migrant aphid composition found on plants in the field. Plant growth was not affected by the kaolin clay, but the fruit had clay residues amongst the bracts of the calyx limiting the use of this product on producing fields to the period before fruit set. Kaolin clay may be best suited to protection of nursery stock, but further work is needed to improve efficacy during wet weather and determine optimal application frequency.Note: Use of trade names or trademarks does not imply endorsement of the companies or products named nor criticism of similar ones not named

Development and adoption of improved chickpea varieties in Myanmar

Chickpea (Cicer arietinum) is an important food legume in Myanmar. It is mainly grown in central dry zone of the country, mainly in Sagaing (54%), Magway (26%) and Mandalay (16%) divisions (Table 1). During 2004–05, the chickpea area in Myanmar was about 205,000 ha, with a production of 239,000 t, and average yield was 1,171 kg ha-1. Chickpea is grown under residual soil moisture in both lowland and upland conditions. In lowland areas, it is grown as a relay or sequential crop after rice (Oryza sativa), while in upland areas it is grown mostly on black soils (Vertisols) with a good water holding capacity after an early short-duration crop of sesame (Sesamum indicum), maize (Zea mays) or pulses or after fallow. Chickpea is also sown along the banks of Ayeyarwaddy River after the flood water recedes

Repetition in abundant landscapes: dynamic approaches to Iron Age and Roman settlement in England

In this paper, we draw attention to several regions of England where the knowledge of Iron Age and Roman settlement has reached a level of ‘abundance’ such that what we can say about the past goes beyond simply creating a gazetteer of ‘sites’, or discussing the pre-sence or absence of particular settlement types. We explore how this level of ‘abundance’ has come about, and what the wider implica-tions are interpretatively and for future work

SCAMP:standardised, concentrated, additional macronutrients, parenteral nutrition in very preterm infants: a phase IV randomised, controlled exploratory study of macronutrient intake, growth and other aspects of neonatal care

<p>Abstract</p> <p>Background</p> <p>Infants born <29 weeks gestation are at high risk of neurocognitive disability. Early postnatal growth failure, particularly head growth, is an important and potentially reversible risk factor for impaired neurodevelopmental outcome. Inadequate nutrition is a major factor in this postnatal growth failure, optimal protein and calorie (macronutrient) intakes are rarely achieved, especially in the first week. Infants <29 weeks are dependent on parenteral nutrition for the bulk of their nutrient needs for the first 2-3 weeks of life to allow gut adaptation to milk digestion. The prescription, formulation and administration of neonatal parenteral nutrition is critical to achieving optimal protein and calorie intake but has received little scientific evaluation. Current neonatal parenteral nutrition regimens often rely on individualised prescription to manage the labile, unpredictable biochemical and metabolic control characteristic of the early neonatal period. Individualised prescription frequently fails to translate into optimal macronutrient delivery. We have previously shown that a standardised, concentrated neonatal parenteral nutrition regimen can optimise macronutrient intake.</p> <p>Methods</p> <p>We propose a single centre, randomised controlled exploratory trial of two standardised, concentrated neonatal parenteral nutrition regimens comparing a standard macronutrient content (maximum protein 2.8 g/kg/day; lipid 2.8 g/kg/day, dextrose 10%) with a higher macronutrient content (maximum protein 3.8 g/kg/day; lipid 3.8 g/kg/day, dextrose 12%) over the first 28 days of life. 150 infants 24-28 completed weeks gestation and birthweight <1200 g will be recruited. The primary outcome will be head growth velocity in the first 28 days of life. Secondary outcomes will include a) auxological data between birth and 36 weeks corrected gestational age b) actual macronutrient intake in first 28 days c) biomarkers of biochemical and metabolic tolerance d) infection biomarkers and other intravascular line complications e) incidence of major complications of prematurity including mortality f) neurodevelopmental outcome at 2 years corrected gestational age</p> <p>Trial registration</p> <p>Current controlled trials: <a href="http://www.controlled-trials.com/ISRCTN76597892">ISRCTN76597892</a>; EudraCT Number: 2008-008899-14</p

Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trial

Treatment with ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) or escalated(e)-BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisolone) remains the international standard of care for advanced-stage classical Hodgkin lymphoma (HL). We performed a retrospective, multicentre analysis of 221 non-trial (“real-world”) patients, aged 16–59 years, diagnosed with advanced-stage HL in the Anglia Cancer Network between 2004 and 2014, treated with ABVD or eBEACOPP, and compared outcomes with 1088 patients in the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma (RATHL) trial, aged 18–59 years, with median follow-up of 87.0 and 69.5 months, respectively. Real-world ABVD patients (n=177) had highly similar 5-year progression-free survival (PFS) and overall survival (OS) compared with RATHL (PFS 79.2% vs 81.4%; OS 92.9% vs 95.2%), despite interim positron-emission tomography-computed tomography (PET/CT)-guided dose-escalation being predominantly restricted to trial patients. Real-world eBEACOPP patients (n=44) had superior PFS (95.5%) compared with real-world ABVD (HR 0.20, p=0.027) and RATHL (HR 0.21, p=0.015), and superior OS for higher-risk (international prognostic score ≥3 [IPS 3+]) patients compared with real-world IPS 3+ ABVD (100% vs 84.5%, p=0.045), but not IPS 3+ RATHL patients. Our data support a PFS, but not OS, advantage for patients with advanced-stage HL treated with eBEACOPP compared with ABVD and suggest higher-risk patients may benefit disproportionately from more intensive therapy. However, increased access to effective salvage therapies might minimise any OS benefit from reduced relapse rates after frontline therapy

Loss of heterozygosity at 7p in Wilms' tumour development

Chromosome 7p alterations have been implicated in the development of Wilms' tumour (WT) by previous studies of tumour cytogenetics, and by our analysis of a constitutional translocation (t(1;7)(q42;p15)) in a child with WT and radial aplasia. We therefore used polymorphic microsatellite markers on 7p for a loss of heterozygosity (LOH) study, and found LOH in seven out of 77 informative WTs (9%). The common region of LOH was 7p15–7p22, which contains the region disrupted by the t(1;7) breakpoint. Four WTs with 7p LOH had other genetic changes; a germline WT1 mutation with 11p LOH, LOH at 11p, LOH at 16q, and loss of imprinting of IGF2. Analysis of three tumour-associated lesions from 7p LOH cases revealed a cystic nephroma-like area also having 7p LOH. However, a nephrogenic rest and a contralateral WT from the two other cases showed no 7p LOH. No particular clinical phenotype was associated with the WTs which showed 7p LOH. The frequency and pattern of 7p LOH demonstrated in our studies indicate the presence of a tumour suppressor gene at 7p involved in the development of Wilms' tumour. © 2000 Cancer Research Campaig

Tellurium substitution effect on superconductivity of the alpha-phase Iron Selenide

We have carried out a systematic study of the PbO-type compound FeSe_{1-x}Te_x (x = 0~1), where Te substitution effect on superconductivity is investigated. It is found that superconducting transition temperature reaches a maximum of Tc=15.2K at about 50% Te substitution. The pressure-enhanced Tc of FeSe0.5Te0.5 is more than 10 times larger than that of FeSe. Interestingly, FeTe is no longer superconducting. A low temperature structural distortion changes FeTe from triclinic symmetry to orthorhombic symmetry. We believe that this structural change breaks the magnetic symmetry and suppresses superconductivity in FeTe.Comment: Some typing errors are corrected; we take out one figures, now the paper has 14 pages, 5 figure

Deletion mapping of chromosome 16q in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) frequently shows an allelic imbalance (AI) on chromosome 16q. In order to define the commonly affected regions on chromosome 16q, we assessed AI studies in 41 HCCs using a panel of 37 microsatellite markers. Thirty-five cases (85%) showed AI at one or more loci. Among the 35 cases with AI, 21 cases showed multiple AI, suggesting the wide scope of deletion on the long arm of chromosome 16, and the remaining 14 cases showed partial AI. Detailed deletion mapping identified two independent commonly deleted regions on this chromosome arm. These included the D16S3106 locus and D16S498 locus. In conclusion, we have demonstrated frequent AI on 16q in HCCs and identified two loci with frequent AI, which may harbour new tumour suppressor genes.ope

Role of friction in pattern formation in oscillated granular layers

Particles in granular flows are often modeled as frictionless (smooth) inelastic spheres; however, there exist no frictionless grains, just as there are no elastic grains. Our molecular dynamics simulations reveal that friction is essential for realistic modeling of vertically oscillated granular layers: simulations of frictionless particles yield patterns with an onset at a container acceleration about 30% smaller than that observed in experiments and simulations with friction. More importantly, even though square and hexagonal patterns form for a wide range of the oscillation parameters in experiments and in our simulations of frictional inelastic particles, only stripe patterns form in the simulations without friction, even if the inelasticity is increased to obtain as much dissipation as in frictional particles. We also consider the effect of particle friction on the shock wave that forms each time the granular layer strikes the container. While a shock wave still forms for frictionless particles, the height and time dependence of the hydrodynamic fields differ for the cases with and without friction.Comment: final version appeared in Phys. Rev.